Interleukin‐10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA
Interleukin‐10 (IL‐10) is an important regulator of immune responses secreted by different cell types. We have previously shown that mice with selective inactivation of the IL‐10 gene in T cells suffer from deregulated T cell responses similar to those observed in IL‐10–/– animals. Unlike IL‐10–/– m...
Saved in:
Published in | European Journal of Immunology Vol. 36; no. 12; pp. 3248 - 3255 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
WILEY‐VCH Verlag
01.12.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Interleukin‐10 (IL‐10) is an important regulator of immune responses secreted by different cell types. We have previously shown that mice with selective inactivation of the IL‐10 gene in T cells suffer from deregulated T cell responses similar to those observed in IL‐10–/– animals. Unlike IL‐10–/– mice, however, T cell‐specific mutants do not mount an enhanced innate immune response to LPS, which must, therefore, be subject to control by IL‐10 from non‐T cells. Herein we show that subcutaneous injection of LPS, which causes moderate local inflammation in WT and T cell‐specific IL‐10 mutant mice, results in augmented inflammatory infiltration and extensive tissue necrosis in mice with deficiency for IL‐10 in macrophages and neutrophils. Correspondingly, we observed an enhanced sensitivity of the macrophage/neutrophil‐specific IL‐10 mutants to systemic LPS exposure when compared with WT animals. In contrast, the inflammatory response of these mutants to CpG oligodeoxynucleotides was not different from that of WT mice. While IL‐10–/– mice developed massive inflammation, necrosis and increased serum cytokine levels after subcutaneous CpG injection, only moderate responses were observed in macrophage/neutrophil‐specific IL‐10 mutant and WT mice. These results show that different innate immune responses can be subject to control by IL‐10 from different cellular sources. |
---|---|
AbstractList | Interleukin-10 (IL-10) is an important regulator of immune responses secreted by different cell types. We have previously shown that mice with selective inactivation of the IL-10 gene in T cells suffer from deregulated T cell responses similar to those observed in IL-10(-/-) animals. Unlike IL-10(-/-) mice, however, T cell-specific mutants do not mount an enhanced innate immune response to LPS, which must, therefore, be subject to control by IL-10 from non-T cells. Herein we show that subcutaneous injection of LPS, which causes moderate local inflammation in WT and T cell-specific IL-10 mutant mice, results in augmented inflammatory infiltration and extensive tissue necrosis in mice with deficiency for IL-10 in macrophages and neutrophils. Correspondingly, we observed an enhanced sensitivity of the macrophage/neutrophil-specific IL-10 mutants to systemic LPS exposure when compared with WT animals. In contrast, the inflammatory response of these mutants to CpG oligodeoxynucleotides was not different from that of WT mice. While IL-10(-/-) mice developed massive inflammation, necrosis and increased serum cytokine levels after subcutaneous CpG injection, only moderate responses were observed in macrophage/neutrophil-specific IL-10 mutant and WT mice. These results show that different innate immune responses can be subject to control by IL-10 from different cellular sources.Interleukin-10 (IL-10) is an important regulator of immune responses secreted by different cell types. We have previously shown that mice with selective inactivation of the IL-10 gene in T cells suffer from deregulated T cell responses similar to those observed in IL-10(-/-) animals. Unlike IL-10(-/-) mice, however, T cell-specific mutants do not mount an enhanced innate immune response to LPS, which must, therefore, be subject to control by IL-10 from non-T cells. Herein we show that subcutaneous injection of LPS, which causes moderate local inflammation in WT and T cell-specific IL-10 mutant mice, results in augmented inflammatory infiltration and extensive tissue necrosis in mice with deficiency for IL-10 in macrophages and neutrophils. Correspondingly, we observed an enhanced sensitivity of the macrophage/neutrophil-specific IL-10 mutants to systemic LPS exposure when compared with WT animals. In contrast, the inflammatory response of these mutants to CpG oligodeoxynucleotides was not different from that of WT mice. While IL-10(-/-) mice developed massive inflammation, necrosis and increased serum cytokine levels after subcutaneous CpG injection, only moderate responses were observed in macrophage/neutrophil-specific IL-10 mutant and WT mice. These results show that different innate immune responses can be subject to control by IL-10 from different cellular sources. Interleukin‐10 (IL‐10) is an important regulator of immune responses secreted by different cell types. We have previously shown that mice with selective inactivation of the IL‐10 gene in T cells suffer from deregulated T cell responses similar to those observed in IL‐10 –/– animals. Unlike IL‐10 –/– mice, however, T cell‐specific mutants do not mount an enhanced innate immune response to LPS, which must, therefore, be subject to control by IL‐10 from non‐T cells. Herein we show that subcutaneous injection of LPS, which causes moderate local inflammation in WT and T cell‐specific IL‐10 mutant mice, results in augmented inflammatory infiltration and extensive tissue necrosis in mice with deficiency for IL‐10 in macrophages and neutrophils. Correspondingly, we observed an enhanced sensitivity of the macrophage/neutrophil‐specific IL‐10 mutants to systemic LPS exposure when compared with WT animals. In contrast, the inflammatory response of these mutants to CpG oligodeoxynucleotides was not different from that of WT mice. While IL‐10 –/– mice developed massive inflammation, necrosis and increased serum cytokine levels after subcutaneous CpG injection, only moderate responses were observed in macrophage/neutrophil‐specific IL‐10 mutant and WT mice. These results show that different innate immune responses can be subject to control by IL‐10 from different cellular sources. Interleukin-10 (IL-10) is an important regulator of immune responses secreted by different cell types. We have previously shown that mice with selective inactivation of the IL-10 gene in T cells suffer from deregulated T cell responses similar to those observed in IL-10(-/-) animals. Unlike IL-10(-/-) mice, however, T cell-specific mutants do not mount an enhanced innate immune response to LPS, which must, therefore, be subject to control by IL-10 from non-T cells. Herein we show that subcutaneous injection of LPS, which causes moderate local inflammation in WT and T cell-specific IL-10 mutant mice, results in augmented inflammatory infiltration and extensive tissue necrosis in mice with deficiency for IL-10 in macrophages and neutrophils. Correspondingly, we observed an enhanced sensitivity of the macrophage/neutrophil-specific IL-10 mutants to systemic LPS exposure when compared with WT animals. In contrast, the inflammatory response of these mutants to CpG oligodeoxynucleotides was not different from that of WT mice. While IL-10(-/-) mice developed massive inflammation, necrosis and increased serum cytokine levels after subcutaneous CpG injection, only moderate responses were observed in macrophage/neutrophil-specific IL-10 mutant and WT mice. These results show that different innate immune responses can be subject to control by IL-10 from different cellular sources. Interleukin-10 (IL-10) is an important regulator of immune responses secreted by different cell types. We have previously shown that mice with selective inactivation of the IL-10 gene in T cells suffer from deregulated T cell responses similar to those observed in IL-10 super(-/-) animals. Unlike IL-10 super(-/-) mice, however, T cell-specific mutants do not mount an enhanced innate immune response to LPS, which must, therefore, be subject to control by IL-10 from non-T cells. Herein we show that subcutaneous injection of LPS, which causes moderate local inflammation in WT and T cell-specific IL-10 mutant mice, results in augmented inflammatory infiltration and extensive tissue necrosis in mice with deficiency for IL-10 in macrophages and neutrophils. Correspondingly, we observed an enhanced sensitivity of the macrophage/neutrophil-specific IL-10 mutants to systemic LPS exposure when compared with WT animals. In contrast, the inflammatory response of these mutants to CpG oligodeoxynucleotides was not different from that of WT mice. While IL-10 super(-/-) mice developed massive inflammation, necrosis and increased serum cytokine levels after subcutaneous CpG injection, only moderate responses were observed in macrophage/neutrophil-specific IL-10 mutant and WT mice. These results show that different innate immune responses can be subject to control by IL-10 from different cellular sources. |
Author | Roers, Axel Krieg, Thomas Müller, Werner Bollati–Fogolin, Mariela Wickenhauser, Claudia Siewe, Lisa |
Author_xml | – sequence: 1 givenname: Lisa surname: Siewe fullname: Siewe, Lisa – sequence: 2 givenname: Mariela surname: Bollati–Fogolin fullname: Bollati–Fogolin, Mariela – sequence: 3 givenname: Claudia surname: Wickenhauser fullname: Wickenhauser, Claudia – sequence: 4 givenname: Thomas surname: Krieg fullname: Krieg, Thomas – sequence: 5 givenname: Werner surname: Müller fullname: Müller, Werner – sequence: 6 givenname: Axel surname: Roers fullname: Roers, Axel email: axel.roers@uni‐koeln.de |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/17111348$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkUFv1DAUhC3Uim5bjlyRT9zSPseOEx-rpZRFq4JEOVtO8tK6JHawnaK9cePKb-SXkLJtQUjQ05PefDOHmX2y47xDQp4zOGIA-TFe26McQHIJLH9CFqzIWSaYYDtkAcBElqsK9sh-jNcAoGShnpI9VjLGuKgW5NvKJQw9Tp-s-_H1OwPaYrA32NIu-IEOpgl-vDKXGKlx7bEP1OGUbn-2jzTg5dSbNIvpCql1XW-GwSQfNrMUR-8i0uTp-v0HWk-JOp9-gX9qy_GMvjo_OSS7nekjPru7B-Tj69OL5Zts_e5stTxZZw0vIc8aFFJ10tSNQZOLmreNkEVRtaZAUdWs4NxAW5Q5F9BAVdVKltiBxI7zrmgUPyAvt7lj8J8njEkPNjbY98ahn6KWVT5Xw8SjIFNSqVLwGXxxB071gK0egx1M2Oj7jmeAb4G5yhgDdrqxySTrXQrG9pqBvl1Sz0vqhyVnV_aX6yH4H3y55b_YHjf_h_Xp29Vv50_8arF8 |
CitedBy_id | crossref_primary_10_4049_jimmunol_1701340 crossref_primary_10_4049_jimmunol_1701582 crossref_primary_10_1016_j_intimp_2016_07_033 crossref_primary_10_1128_IAI_00825_07 crossref_primary_10_1371_journal_pone_0213813 crossref_primary_10_1038_srep42851 crossref_primary_10_1128_IAI_01148_13 crossref_primary_10_3390_jcm8111981 crossref_primary_10_4049_jimmunol_1102755 crossref_primary_10_1681_ASN_2012070684 crossref_primary_10_1002_eji_201041307 crossref_primary_10_1016_j_immuni_2016_05_005 crossref_primary_10_1016_j_immuni_2014_03_012 crossref_primary_10_1016_j_febslet_2014_01_015 crossref_primary_10_1155_2014_481750 crossref_primary_10_1111_imr_12208 crossref_primary_10_3389_fimmu_2019_02402 crossref_primary_10_1111_vco_12529 crossref_primary_10_1016_j_thromres_2024_109236 crossref_primary_10_1016_j_clim_2012_02_005 crossref_primary_10_1016_j_ejphar_2011_09_166 crossref_primary_10_1073_pnas_1219852110 crossref_primary_10_1016_j_cytogfr_2010_09_002 crossref_primary_10_1097_SHK_0b013e318225ad7e crossref_primary_10_2217_dmt_15_44 crossref_primary_10_1371_journal_pone_0137366 crossref_primary_10_1016_j_neuropharm_2024_109890 crossref_primary_10_3389_fimmu_2020_01794 crossref_primary_10_1038_nri2711 crossref_primary_10_1042_BSR20201859 crossref_primary_10_4049_jimmunol_1201126 crossref_primary_10_1074_jbc_M110_207738 crossref_primary_10_1371_journal_ppat_1004049 crossref_primary_10_1002_eji_200939592 crossref_primary_10_1371_journal_ppat_1003476 crossref_primary_10_1016_j_jaci_2011_08_032 crossref_primary_10_1016_j_livsci_2011_12_006 crossref_primary_10_1126_sciadv_adu4369 crossref_primary_10_4049_jimmunol_0900788 crossref_primary_10_1177_1933719108325757 crossref_primary_10_1016_j_jneuroim_2016_04_010 crossref_primary_10_4049_jimmunol_1601340 crossref_primary_10_1371_journal_pone_0154621 crossref_primary_10_1016_j_clim_2011_08_012 crossref_primary_10_1158_2326_6066_CIR_14_0169 crossref_primary_10_1038_icb_2010_40 crossref_primary_10_4049_jimmunol_181_9_5956 crossref_primary_10_1007_s12026_009_8150_5 crossref_primary_10_1038_ncomms8055 crossref_primary_10_1074_jbc_RA117_000158 crossref_primary_10_1016_j_febslet_2007_08_015 crossref_primary_10_1128_iai_00360_23 crossref_primary_10_1007_s12032_017_1055_6 crossref_primary_10_1371_journal_ppat_1003735 crossref_primary_10_1002_eji_200838184 crossref_primary_10_1073_pnas_2018278118 crossref_primary_10_1155_2011_383962 crossref_primary_10_3390_ijms20236008 crossref_primary_10_4049_jimmunol_1800070 crossref_primary_10_3389_fimmu_2018_02625 crossref_primary_10_1016_j_chom_2013_05_013 crossref_primary_10_1016_j_celrep_2023_112171 crossref_primary_10_1074_jbc_M117_805424 crossref_primary_10_1371_journal_pone_0169531 crossref_primary_10_1111_j_1365_3083_2012_02695_x crossref_primary_10_1002_ibd_21587 crossref_primary_10_1155_2018_4315140 crossref_primary_10_1016_j_bbrc_2008_02_043 crossref_primary_10_4049_jimmunol_1103421 crossref_primary_10_1038_ni_1640 crossref_primary_10_1016_j_imbio_2015_06_019 crossref_primary_10_1073_pnas_0904955106 crossref_primary_10_1016_j_immuni_2008_03_003 crossref_primary_10_1016_j_micinf_2011_12_012 crossref_primary_10_1007_s00535_015_1084_x crossref_primary_10_1016_j_intimp_2022_108920 crossref_primary_10_1016_j_cellimm_2007_01_008 crossref_primary_10_1111_pim_12297 crossref_primary_10_1016_j_biomaterials_2017_06_013 crossref_primary_10_1016_j_coi_2007_05_007 crossref_primary_10_3923_ijp_2014_389_397 crossref_primary_10_1016_j_intimp_2017_02_004 crossref_primary_10_1016_j_theriogenology_2014_04_022 crossref_primary_10_4049_jimmunol_0900185 crossref_primary_10_1089_jop_2014_0018 crossref_primary_10_4049_jimmunol_0803883 crossref_primary_10_1007_s12035_019_01757_9 crossref_primary_10_1182_bloodadvances_2018026450 crossref_primary_10_1038_s41590_019_0316_2 crossref_primary_10_4049_jimmunol_1200360 crossref_primary_10_1371_journal_ppat_1004873 crossref_primary_10_4049_jimmunol_1101477 crossref_primary_10_1371_journal_ppat_1002173 crossref_primary_10_1084_jem_20070104 crossref_primary_10_1016_j_smim_2019_101344 crossref_primary_10_1186_ar4544 crossref_primary_10_3389_fimmu_2024_1250818 |
Cites_doi | 10.1146/annurev.immunol.20.100301.064842 10.1002/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8 10.4049/jimmunol.147.11.3815 10.4049/jimmunol.175.6.3569 10.1084/jem.20020732 10.4049/jimmunol.157.2.798 10.4049/jimmunol.174.12.8064 10.1086/320731 10.1016/S1074-7613(01)00227-8 10.1016/j.immuni.2005.02.008 10.4049/jimmunol.175.2.1041 10.1038/374546a0 10.1038/nri1004 10.1182/blood-2003-07-2465 10.1016/0092-8674(93)80068-P 10.1128/IAI.66.11.5157-5166.1998 10.1128/IAI.69.7.4561-4571.2001 10.1189/jlb.0602325 10.1038/nri1460 10.1038/35100529 10.1084/jem.182.1.99 10.1146/annurev.immunol.19.1.683 10.1084/jem.20041789 10.1023/A:1008942828960 10.1016/S0952-7915(02)00013-4 10.4049/jimmunol.157.5.2116 10.1007/s00335-004-2392-2 10.1073/pnas.0400983101 10.1172/JCI118290 |
ContentType | Journal Article |
Copyright | Copyright © 2006 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim |
Copyright_xml | – notice: Copyright © 2006 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TM H94 7X8 |
DOI | 10.1002/eji.200636012 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Nucleic Acids Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Immunology Abstracts Nucleic Acids Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1521-4141 1365-2567 |
EndPage | 3255 |
ExternalDocumentID | 17111348 10_1002_eji_200636012 EJI200636012 |
Genre | article Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GrantInformation_xml | – fundername: Deutsche Forschungsgemeinschaft (DFG) funderid: SFB 589; SFB 621 |
GroupedDBID | --- .3N .55 .GA .GJ .HR .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 24P 31~ 33P 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEFU ABEML ABIJN ABJNI ABLJU ABPVW ABQWH ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFS ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AI. AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOETA ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 CS3 D-E D-F DCZOG DPXWK DR2 DRFUL DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M J5H JPC KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M65 MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ NNB O66 O9- OHT OIG OK1 OVD P2P P2W P2X P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RGB RIWAO RJQFR ROL RWI RX1 SAMSI SUPJJ SV3 TEORI UB1 UPT V2E VH1 W8V W99 WBKPD WHWMO WIB WIH WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WXSBR X7M XG1 XPP XV2 Y6R ZGI ZXP ZZTAW ~IA ~KM ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM -~X 29I 2WC 36B 52R 52V 5HH 5LA 7T5 7TM A01 A8Z AAFWJ AAMMB ABDBF ABXGK ACGFO ACGOF ACIWK ACMXC ACNCT ACUHS ADBTR AEFGJ AEGXH AFEBI AGXDD AIACR AIAGR AIDQK AIDYY AOIJS BAWUL C45 CAG COF D-6 D-7 DIK DRMAN E3Z EAD EAP EAS EBB EBC EBX EMB EMK EPT ESX EX3 FD6 FIJ FUBAC GX1 H94 HZI IH2 IHE K48 KBYEO MRMAN MSMAN MXMAN OBC OBS P2Z P4B Q~Q RPM TR2 TUS V8K WH7 WIJ WOQ WOW WXI YF5 YFH YOC YUY 7X8 |
ID | FETCH-LOGICAL-c3702-ce469f6abcaea24b3dc46558da5e48b1533a0d572340c088b967ef06ef33f5c93 |
IEDL.DBID | DR2 |
ISSN | 0014-2980 |
IngestDate | Fri Jul 11 00:55:58 EDT 2025 Fri Jul 11 01:18:06 EDT 2025 Wed Feb 19 01:46:47 EST 2025 Tue Jul 01 00:48:37 EDT 2025 Thu Apr 24 23:00:45 EDT 2025 Wed Jan 22 16:45:18 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3702-ce469f6abcaea24b3dc46558da5e48b1533a0d572340c088b967ef06ef33f5c93 |
Notes | The first two authors as well as the last two authors contributed equally to this work. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
PMID | 17111348 |
PQID | 19699743 |
PQPubID | 23462 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_68211114 proquest_miscellaneous_19699743 pubmed_primary_17111348 crossref_citationtrail_10_1002_eji_200636012 crossref_primary_10_1002_eji_200636012 wiley_primary_10_1002_eji_200636012_EJI200636012 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | December 2006 |
PublicationDateYYYYMMDD | 2006-12-01 |
PublicationDate_xml | – month: 12 year: 2006 text: December 2006 |
PublicationDecade | 2000 |
PublicationPlace | Weinheim |
PublicationPlace_xml | – name: Weinheim – name: Germany |
PublicationTitle | European Journal of Immunology |
PublicationTitleAlternate | Eur J Immunol |
PublicationYear | 2006 |
Publisher | WILEY‐VCH Verlag |
Publisher_xml | – name: WILEY‐VCH Verlag |
References | 2004; 200 2004; 101 1995; 96 1998; 28 2001; 183 2005; 174 2005; 175 2002; 196 2004; 4 2003; 15 1999; 8 1995; 374 2003; 73 2001; 69 2005; 22 1998; 66 1991; 147 2002; 20 2004; 15 1993; 75 2001; 19 2003; 3 2001; 15 2001; 1 1996; 157 2003; 102 1995; 182 Gazzinelli R. T. (e_1_2_6_9_2) 1996; 157 Stacey K. J. (e_1_2_6_16_2) 1996; 157 e_1_2_6_18_2 e_1_2_6_19_2 e_1_2_6_12_2 e_1_2_6_13_2 e_1_2_6_10_2 e_1_2_6_11_2 e_1_2_6_17_2 e_1_2_6_14_2 e_1_2_6_15_2 Fiorentino D. F. (e_1_2_6_20_2) 1991; 147 Kullberg M. C. (e_1_2_6_7_2) 1998; 66 e_1_2_6_8_2 e_1_2_6_29_2 e_1_2_6_4_2 e_1_2_6_3_2 e_1_2_6_6_2 e_1_2_6_5_2 e_1_2_6_24_2 e_1_2_6_23_2 e_1_2_6_2_2 e_1_2_6_22_2 e_1_2_6_1_2 e_1_2_6_21_2 e_1_2_6_28_2 e_1_2_6_27_2 e_1_2_6_26_2 e_1_2_6_25_2 |
References_xml | – volume: 182 start-page: 99 year: 1995 end-page: 108 article-title: Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. publication-title: J. Exp. Med. – volume: 28 start-page: 2045 year: 1998 end-page: 2054 article-title: Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. publication-title: Eur. J. Immunol. – volume: 374 start-page: 546 year: 1995 end-page: 549 article-title: CpG motifs in bacterial DNA trigger direct B‐cell activation. publication-title: Nature – volume: 102 start-page: 4487 year: 2003 end-page: 4492 article-title: IL‐10 regulates plasmacytoid dendritic cell response to CpG‐containing immunostimulatory sequences. publication-title: Blood – volume: 69 start-page: 4561 year: 2001 end-page: 4571 article-title: Endogenous interleukin‐10 is required for prevention of a hyperinflammatory intracerebral immune response in meningoencephalitis. publication-title: Infect. Immun. – volume: 15 start-page: 5 year: 2003 end-page: 11 article-title: Mammalian Toll‐like receptors. publication-title: Curr. Opin. Immunol. – volume: 15 start-page: 865 year: 2004 end-page: 871 article-title: Refined histopathologic scoring system improves power to detect colitis QTL in mice. publication-title: Mamm. Genome – volume: 175 start-page: 3569 year: 2005 end-page: 3576 article-title: Differences in macrophage activation by bacterial DNA and CpG‐containing oligonucleotides. publication-title: J. Immunol. – volume: 66 start-page: 5157 year: 1998 end-page: 5166 article-title: triggers colitis in specific‐pathogen‐free interleukin‐10 (IL‐10)‐deficient mice through an IL‐12‐ and gamma interferon‐dependent mechanism. publication-title: Infect. Immun. – volume: 157 start-page: 798 year: 1996 end-page: 805 article-title: In the absence of endogenous IL‐10, mice acutely infected with succumb to a lethal immune response dependent on CD4 T cells and accompanied by overproduction of IL‐12, IFN‐gamma and TNF‐alpha. publication-title: J. Immunol. – volume: 96 start-page: 2339 year: 1995 end-page: 2347 article-title: Interleukin‐10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. publication-title: J. Clin. Invest. – volume: 22 start-page: 467 year: 2005 end-page: 477 article-title: Upon TLR9 signaling, CD5 B cells control the IL‐12‐dependent Th1‐priming capacity of neonatal DCs. publication-title: Immunity – volume: 157 start-page: 2116 year: 1996 end-page: 2122 article-title: Macrophages ingest and are activated by bacterial DNA. publication-title: J. Immunol. – volume: 175 start-page: 1041 year: 2005 end-page: 1046 article-title: Identification of a macrophage‐specific chromatin signature in the IL‐10 locus. publication-title: J. Immunol. – volume: 3 start-page: 169 year: 2003 end-page: 76 article-title: Innate immune sensing and its roots: the story of endotoxin. publication-title: Nat. Rev. Immunol. – volume: 15 start-page: 763 year: 2001 end-page: 774 article-title: A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. publication-title: Immunity – volume: 200 start-page: 1289 year: 2004 end-page: 1297 article-title: T cell‐specific inactivation of the interleukin‐10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. publication-title: J. Exp. Med. – volume: 1 start-page: 135 year: 2001 end-page: 145 article-title: Toll‐like receptors and innate immunity. publication-title: Nat. Rev. Immunol. – volume: 75 start-page: 263 year: 1993 end-page: 274 article-title: Interleukin‐10‐deficient mice develop chronic enterocolitis. publication-title: Cell – volume: 8 start-page: 265 year: 1999 end-page: 277 article-title: Conditional gene targeting in macrophages and granulocytes using LysM‐cre mice. publication-title: Transgenic Research – volume: 73 start-page: 209 year: 2003 end-page: 212 article-title: The many faces of macrophage activation. publication-title: J. Leukoc. Biol. – volume: 174 start-page: 8064 year: 2005 end-page: 8071 article-title: Involvement of SHIP in TLR2‐induced neutrophil activation and acute lung injury. publication-title: J. Immunol. – volume: 183 start-page: 1794 year: 2001 end-page: 1800 article-title: Relative contribution of interferon‐gamma and interleukin‐10 to resistance to murine African trypanosomosis. publication-title: J. Infect. Dis. – volume: 147 start-page: 3815 year: 1991 end-page: 3822 article-title: IL‐10 inhibits cytokine production by activated macrophages. publication-title: J. Immunol. – volume: 101 start-page: 4560 year: 2004 end-page: 4565 article-title: Human IL‐23‐producing type 1 macrophages promote but IL‐10‐producing type 2 macrophages subvert immunity to (myco)bacteria. publication-title: Proc. Natl. Acad. Sci. USA – volume: 20 start-page: 709 year: 2002 end-page: 760 article-title: CpG motifs in bacterial DNA and their immune effects. publication-title: Annu. Rev. Immunol. – volume: 19 start-page: 683 year: 2001 end-page: 765 article-title: Interleukin‐10 and the interleukin‐10 receptor. publication-title: Annu. Rev. Immunol. – volume: 196 start-page: 541 year: 2002 end-page: 549 article-title: Reversal of tumor‐induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti‐interleukin 10 receptor antibody. publication-title: J. Exp. Med. – volume: 4 start-page: 787 year: 2004 end-page: 799 article-title: Mast‐cell responses to pathogens. publication-title: Nat. Rev. Immunol. – ident: e_1_2_6_4_2 doi: 10.1146/annurev.immunol.20.100301.064842 – ident: e_1_2_6_25_2 doi: 10.1002/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8 – volume: 147 start-page: 3815 year: 1991 ident: e_1_2_6_20_2 article-title: IL‐10 inhibits cytokine production by activated macrophages. publication-title: J. Immunol. doi: 10.4049/jimmunol.147.11.3815 – ident: e_1_2_6_17_2 doi: 10.4049/jimmunol.175.6.3569 – ident: e_1_2_6_19_2 doi: 10.1084/jem.20020732 – volume: 157 start-page: 798 year: 1996 ident: e_1_2_6_9_2 article-title: In the absence of endogenous IL‐10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL‐12, IFN‐gamma and TNF‐alpha. publication-title: J. Immunol. doi: 10.4049/jimmunol.157.2.798 – ident: e_1_2_6_24_2 doi: 10.4049/jimmunol.174.12.8064 – ident: e_1_2_6_10_2 doi: 10.1086/320731 – ident: e_1_2_6_29_2 doi: 10.1016/S1074-7613(01)00227-8 – ident: e_1_2_6_27_2 doi: 10.1016/j.immuni.2005.02.008 – ident: e_1_2_6_22_2 doi: 10.4049/jimmunol.175.2.1041 – ident: e_1_2_6_28_2 doi: 10.1038/374546a0 – ident: e_1_2_6_3_2 doi: 10.1038/nri1004 – ident: e_1_2_6_18_2 doi: 10.1182/blood-2003-07-2465 – ident: e_1_2_6_6_2 doi: 10.1016/0092-8674(93)80068-P – volume: 66 start-page: 5157 year: 1998 ident: e_1_2_6_7_2 article-title: Helicobacter hepaticus triggers colitis in specific‐pathogen‐free interleukin‐10 (IL‐10)‐deficient mice through an IL‐12‐ and gamma interferon‐dependent mechanism. publication-title: Infect. Immun. doi: 10.1128/IAI.66.11.5157-5166.1998 – ident: e_1_2_6_8_2 doi: 10.1128/IAI.69.7.4561-4571.2001 – ident: e_1_2_6_23_2 doi: 10.1189/jlb.0602325 – ident: e_1_2_6_26_2 doi: 10.1038/nri1460 – ident: e_1_2_6_1_2 doi: 10.1038/35100529 – ident: e_1_2_6_12_2 doi: 10.1084/jem.182.1.99 – ident: e_1_2_6_5_2 doi: 10.1146/annurev.immunol.19.1.683 – ident: e_1_2_6_13_2 doi: 10.1084/jem.20041789 – ident: e_1_2_6_15_2 doi: 10.1023/A:1008942828960 – ident: e_1_2_6_2_2 doi: 10.1016/S0952-7915(02)00013-4 – volume: 157 start-page: 2116 year: 1996 ident: e_1_2_6_16_2 article-title: Macrophages ingest and are activated by bacterial DNA. publication-title: J. Immunol. doi: 10.4049/jimmunol.157.5.2116 – ident: e_1_2_6_14_2 doi: 10.1007/s00335-004-2392-2 – ident: e_1_2_6_21_2 doi: 10.1073/pnas.0400983101 – ident: e_1_2_6_11_2 doi: 10.1172/JCI118290 |
SSID | ssj0009659 ssj0013055 |
Score | 2.2200522 |
Snippet | Interleukin‐10 (IL‐10) is an important regulator of immune responses secreted by different cell types. We have previously shown that mice with selective... Interleukin-10 (IL-10) is an important regulator of immune responses secreted by different cell types. We have previously shown that mice with selective... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 3248 |
SubjectTerms | Adjuvants, Immunologic - administration & dosage Animals Cells, Cultured CpG Islands - immunology Cytokines Inflammation Inflammation Mediators - metabolism Inflammation Mediators - physiology Interleukin-10 - deficiency Interleukin-10 - genetics Interleukin-10 - physiology Knock‐out mice Lipopolysaccharides - administration & dosage Lipopolysaccharides - immunology Macrophages Macrophages - immunology Macrophages - metabolism Mice Mice, Inbred C57BL Mice, Knockout Mice, Transgenic Neutrophils Neutrophils - immunology Neutrophils - metabolism Oligodeoxyribonucleotides - administration & dosage Oligodeoxyribonucleotides - immunology |
Title | Interleukin‐10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Feji.200636012 https://www.ncbi.nlm.nih.gov/pubmed/17111348 https://www.proquest.com/docview/19699743 https://www.proquest.com/docview/68211114 |
Volume | 36 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NTxQxFG8IicSLAn6wgtiD8eSwnbbzdSQIAhFiVBJuYz_DwjJDdmdM4MTNq3-jf4mv7eyui8HEeJz2NdPpvM--9vcQek0TmlkuVWQ1hQAlZkkkHeIQWEJqMy0K7auWHB2n-yf88DQ57eqcurswAR9iuuHmJMPrayfgQo77M9BQcz7wmQMGIYXTwe68lnOKPs3goxxYXtDEPKJFTjqMTRjfnxs9b5P-cDTn_VZvePYeo6-TKYfzJhdbbSO31M0dNMf_-KZl9KhzSvF24KIVtGCqVfQglKm8XkVLR10C_gn67ncQh6a9GFQ_b3_EBGtg4W9GY3dPBV8KVxHsDHTUGItK9-sRrkzbuLbBcIxHofA9dILbiYG3gR0vfZofuvxZXYObGn_4-BnLtsFV3XjC3_t2rt7jd8fbT9HJ3u6Xnf2oq-UQKZaB0lUG4nCbCqmEEZRLppVDbsu1SAzPpfM6BdFJRhknCjSfLNLMWJIay5hNVMGeocWqrswawrnREOQpIS1XPFZEZAU1xBKRiziV3PbQ28nfLFUHdO7qbQzLANFMS1jmcrrMPfRmSn4VED7uI3w1YY0SZNAlVkRl6nZcOoghiMvY_RRpTp1t4j30PPDU7FUZtDOe9xDxnPH3OZS7hwfThxf_PmQdPaRd5SUSb6DFZtSal-BVNXLTi84vr8kaMQ |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Lb9MwGLfQ0GAXGANGec0HxImsju28jtMedKOtEGzSbpGfrFuXTG2CBCduXPkb-Uv47KTtChoS4hj7c-I439Of8_sQekUjmlguVWA1hQAlZFEgHeIQWEJqEy0y7auWDIZx74QfnUan1_7ib_Ah5htuTjK8vnYC7jakuwvUUHM-8qkDBjEFKOHbrqq3Q8_f-7AAkHJweY0u5gHNUtKibMINukvDl63SH67msufqTc_BfSRmk25OnFxs15XcVl9_w3P8n7daR_davxTvNIz0AN0yxQZabSpVftlAdwZtDv4h-u43EcemvhgVP7_9CAnWwMWfjcbuVxV8KVxRsDNQU1MsCt0tJ7gwdeXaRuMpnphPrmAYdILniYG9gSMvfaYfuvxxXYOrEvfff8SyrnBRVp7wet_u1Vu8N9x5hE4O9o93e0FbziFQLAG9qwyE4jYWUgkjKJdMKwfelmoRGZ5K53gKoqOEMk4UKD-ZxYmxJDaWMRupjD1GK0VZmCcIp0ZDnKeEtFzxUBGRZNQQS0Qqwlhy20FvZp8zVy3WuSu5Mc4blGaawzLn82XuoNdz8qsG5OMmwq0Zb-Qghi63IgpT1tPcoQxBaMZupohT6swT76DNhqkWj0qgnfG0g4hnjb_PId8_OpxfPP33IVvobu940M_7h8N3z9AabQsxkfA5WqkmtXkBTlYlX3o5-gVINh5N |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9MwHLfQEBMXHgNGgTEfECeyOrbzOk7rugdbNQGTdgt-irIuqdoEiZ1223WfkU_C307aUtCQEMf4kTjO_2k7vx9Cb2hEE8ulCqymkKCELAqkQxwCT0htokWmPWvJ8SDeP-WHZ9FZy3Pq_oVp8CHmC25OM7y9dgo-1ra7AA01X4d-54BBSgE2-C6PSea4G3ofFvhRDi2vMcU8oFlKWpBNuEF3qfuyU_oj0lwOXL3n6T9En2djbg6cnG_VldxSl7_BOf7HSz1CD9qoFG83YvQY3THFGrrX8FR-X0Orx-0O_BN07ZcQR6Y-HxY_rm5CgjXI8DejsftRBV8IRwn2BYzUFItCd8sJLkxdubLhaIonDfM9VELciUG4QR4v_D4_VPnDugZXJT46-YhlXeGirHzDX-t2xnu4N9h-ik77u5929oOWzCFQLAGrqwwk4jYWUgkjKJdMKwfdlmoRGZ5KF3YKoqOEMk4UmD6ZxYmxJDaWMRupjD1DK0VZmOcIp0ZDlqeEtFzxUBGRZNQQS0Qqwlhy20HvZl8zVy3SuSPcGOUNRjPNYZrz-TR30Nt583ED8XFbw82ZaOSghG5nRRSmrKe5wxiCxIzd3iJOqXNOvIPWG5laPCqBcsbTDiJeMv4-hnz38GB-8eLfu2yi1ZNePz86GLx_ie7TloWJhK_QSjWpzQZEWJV87bXoJ9InHPw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Interleukin-10+derived+from+macrophages+and%2For+neutrophils+regulates+the+inflammatory+response+to+LPS+but+not+the+response+to+CpG+DNA&rft.jtitle=European+journal+of+immunology&rft.au=Siewe%2C+Lisa&rft.au=Bollati-Fogolin%2C+Mariela&rft.au=Wickenhauser%2C+Claudia&rft.au=Krieg%2C+Thomas&rft.date=2006-12-01&rft.issn=0014-2980&rft.volume=36&rft.issue=12&rft.spage=3248&rft_id=info:doi/10.1002%2Feji.200636012&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0014-2980&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0014-2980&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0014-2980&client=summon |